Xinnian Yu

582 total citations
21 papers, 360 citations indexed

About

Xinnian Yu is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Xinnian Yu has authored 21 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Xinnian Yu's work include Cancer-related molecular mechanisms research (8 papers), RNA Research and Splicing (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xinnian Yu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA Research and Splicing (4 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Xinnian Yu collaborates with scholars based in China, India and United States. Xinnian Yu's co-authors include Shanliang Zhong, Feng Jiang, Gaochao Dong, Qixing Mao, Lin Xu, Huixin Li, Xuming Song, Wenjie Xia, Xiaolin Liu and Anpeng Wang and has published in prestigious journals such as Cell Death and Differentiation, Frontiers in Immunology and Cell Death and Disease.

In The Last Decade

Xinnian Yu

20 papers receiving 359 citations

Peers

Xinnian Yu

PRM

ONCOL

IMMUN

Lin-ang Wang China

Mingxu Da China

Da‐Lei Zhou China

Moubin Lin China

Aya Shiba‐Ishii Japan

Naoki Ogane Japan

Michiel F.G. de Maat Netherlands

Harlinde De Schutter Belgium

Yuxia Zhao China

Yukari Ishiguro Japan

Lin-ang Wang China

Xinnian Yu

189 ×1.0

117 ×0.8

76 ×0.9

PRM

111 ×1.4

ONCOL

56 ×1.2

IMMUN

Citations per year, relative to Xinnian Yu Xinnian Yu (= 1×) peers Lin-ang Wang

Countries citing papers authored by Xinnian Yu

Since Specialization

Citations

This map shows the geographic impact of Xinnian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinnian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinnian Yu more than expected).

Fields of papers citing papers by Xinnian Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinnian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinnian Yu. The network helps show where Xinnian Yu may publish in the future.

Co-authorship network of co-authors of Xinnian Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinnian Yu. A scholar is included among the top collaborators of Xinnian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinnian Yu. Xinnian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sun, Yan, et al.. (2025). Retrospective study on the prognostic prediction of inflammatory markers and the C-reactive protein/albumin ratio in first-line immunotherapy for advanced HER2 negative gastric cancer patients. Translational Cancer Research. 14(3). 2043–2053.

Zhang, Yijian, Anpeng Wang, Hui Wang, et al.. (2024). The recruitment of CD8+ T cells through YBX1 stabilization abrogates tumor intrinsic oncogenic role of MIR155HG in lung adenocarcinoma. Cell Death Discovery. 10(1). 334–334. 3 indexed citations

Zhang, Te, Zeyu Zhang, Hui Wang, et al.. (2023). The super-enhancer-driven lncRNA LINC00880 acts as a scaffold between CDK1 and PRDX1 to sustain the malignance of lung adenocarcinoma. Cell Death and Disease. 14(8). 551–551. 15 indexed citations

Wang, Hui, Yingkuan Liang, Te Zhang, et al.. (2023). C-IGF1R encoded by cIGF1R acts as a molecular switch to restrict mitophagy of drug-tolerant persister tumour cells in non-small cell lung cancer. Cell Death and Differentiation. 30(11). 2365–2381. 16 indexed citations

Wang, Hui, Xuming Song, Te Zhang, et al.. (2023). Tobacco exposure primes the secretion of CCL21 positively associated with tertiary lymphoid structure and response to immunotherapy. Journal for ImmunoTherapy of Cancer. 11(6). e006939–e006939. 15 indexed citations

Yu, Xinnian, et al.. (2023). Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma. Frontiers in Immunology. 14. 1145300–1145300. 41 indexed citations

Yu, Xinnian, Huixin Li, Yuqi Fu, et al.. (2023). Single-cell RNA-seq reveals MIF−(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma. Oral Oncology. 148. 106654–106654. 8 indexed citations

Zhang, Te, Wenjie Xia, Xuming Song, et al.. (2022). Super-enhancer hijacking LINC01977 promotes malignancy of early-stage lung adenocarcinoma addicted to the canonical TGF-β/SMAD3 pathway. Journal of Hematology & Oncology. 15(1). 114–114. 45 indexed citations

Yu, Xinnian, et al.. (2022). tRF-20-S998LO9D Inhibits Endometrial Carcinoma by Upregulating SESN2. Epigenomics. 14(24). 1563–1577. 12 indexed citations

10.

Wang, Xiaojun, Xinnian Yu, Wei Wei, & Yuanhua Liu. (2020). Long noncoding RNA MACC1‐AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1‐mediated destabilization of LATS1/2. Environmental Toxicology. 35(9). 998–1006. 20 indexed citations

11.

Zhong, Shanliang, Siying Zhou, Su‐Jin Yang, et al.. (2019). Identification of internal control genes for circular RNAs. Biotechnology Letters. 41(10). 1111–1119. 18 indexed citations

12.

Ma, Dawei, Rong Ma, Jianqiu Wu, et al.. (2019). Pre‐miR‐27a rs895819 polymorphism and risk of diffuse large B‐cell lymphoma. Journal of Clinical Laboratory Analysis. 34(3). e23088–e23088. 7 indexed citations

13.

Xia, Wenjie, Xinnian Yu, Qixing Mao, et al.. (2017). Improvement of survival for non-small cell lung cancer over time. OncoTargets and Therapy. Volume 10. 4295–4303. 46 indexed citations

14.

Yu, Xinnian, Siying Zhou, Jinyan Wang, et al.. (2017). Hormone replacement therapy and breast cancer survival: a systematic review and meta-analysis of observational studies. Breast Cancer. 24(5). 643–657. 20 indexed citations

15.

Shi, Run, Xinnian Yu, Yajing Wang, et al.. (2017). Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non–small cell lung cancer. Tumor Biology. 39(4). 3726131192–3726131192. 25 indexed citations

16.

Zhong, Shanliang, Zhiyuan Chen, Xinnian Yu, et al.. (2014). A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in breast cancer. Molecular Biology Reports. 41(9). 5775–5785. 15 indexed citations

17.

Zhong, Shanliang, Zhiyuan Chen, Xinnian Yu, et al.. (2014). Tea consumption and leukemia risk: a meta-analysis. Tumor Biology. 35(6). 5205–5212. 10 indexed citations

18.

Yu, Xinnian, et al.. (2014). The interleukin-10-1082A>G polymorphism and lymphoma risk: A meta-analysis. Cancer Biomarkers. 14(5). 381–388. 2 indexed citations

19.

Zhong, Shanliang, et al.. (2013). Coffee consumption and risk of prostate cancer: an up-to-date meta-analysis. European Journal of Clinical Nutrition. 68(3). 330–337. 14 indexed citations

20.

Yu, Xinnian & Baoan Chen. (2013). [Progress of microRNA in diagnosis and prognosis of diffuse large B cell lymphoma-review].. PubMed. 21(5). 1351–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact